{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:02:43Z","timestamp":1781708563677,"version":"3.54.5"},"reference-count":141,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The pathological features of antiphospholipid syndrome (APS) are related to the activity of circulating antiphospholipid antibodies (aPLs) associated with vascular thrombosis and obstetric complications. Indeed, aPLs are not only disease markers, but also play a determining pathogenetic role in APS and exert their effects through the activation of cells and coagulation factors and inflammatory mediators for the materialization of the thromboinflammatory pathogenetic mechanism. Cellular activation in APS necessarily involves the interaction of aPLs with target receptors on the cell membrane, capable of triggering the signal transduction pathway(s). This interaction occurs at specific microdomains of the cell plasma membrane called lipid rafts. In this review, we focus on the key role of lipid rafts as signaling platforms in the pathogenesis of APS, and propose this pathogenetic step as a strategic target of new therapies in order to improve classical anti-thrombotic approaches with \u201cnew\u201d immunomodulatory drugs.<\/jats:p>","DOI":"10.3390\/jcm12030891","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T04:50:41Z","timestamp":1674449441000},"page":"891","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts"],"prefix":"10.3390","volume":"12","author":[{"given":"Antonella","family":"Capozzi","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Manganelli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Riitano","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Caissutti","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-2510","authenticated-orcid":false,"given":"Tina","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3534-1502","authenticated-orcid":false,"given":"Maurizio","family":"Sorice","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Misasi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Andreoli","year":"2017","journal-title":"J. Autoimmun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J. Autoimmun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"932181","DOI":"10.3389\/fimmu.2022.932181","article-title":"Relationship Between Gender Differences and Clinical Outcome in Patients with the Antiphospholipid Syndrome","volume":"4","author":"Truglia","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0036-1592336","article-title":"Pregnancy and antiphospholipid syndrome","volume":"42","author":"Schreiber","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2362.2010.02263.x","article-title":"Neurological manifestations of antiphospholipid syndrome","volume":"40","author":"Rodrigues","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1191\/0961203303lu500oa","article-title":"CNS dysfunction in the antiphospholipid syndrome","volume":"12","author":"Katzav","year":"2003","journal-title":"Lupus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u201cmultiple sclerosis\u201d. Neurological features of the antiphospholipid (Hughes\u2019) syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgrad. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: A prospective cohort study","volume":"98","author":"Hacihanefioglu","year":"2001","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.blre.2008.03.005","article-title":"The hematologic manifestations of the antiphospholipid syndrome","volume":"22","author":"Uthman","year":"2008","journal-title":"Blood Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: Two hundred consecutive cases","volume":"52","author":"Frances","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_15","first-page":"10","article-title":"Cutaneous manifestations of antiphospholipid syndrome: A review of the clinical features, diagnosis and management","volume":"38","author":"Caetano","year":"2013","journal-title":"Acta Reumatol. Port."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/096120339800700214","article-title":"The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment","volume":"7","author":"Asherson","year":"1998","journal-title":"Lupus"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1024\/0301-1526\/a000723","article-title":"Antiphospholipid syndrome\u2014An update","volume":"47","author":"Linnemann","year":"2018","journal-title":"Vasa"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.autrev.2014.05.001","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends","volume":"13","author":"Bertolaccini","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood-2004-03-1107","article-title":"Beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome","volume":"104","author":"Derksen","year":"2004","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13317-011-0017-9","article-title":"Pathophysiology of the antiphospholipid antibody syndrome","volume":"2","author":"Willis","year":"2011","journal-title":"Autoimmun. Highlights"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.berh.2007.09.005","article-title":"Antiphospholipid syndrome (APS): Where does it come from?","volume":"21","author":"Sherer","year":"2007","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.berh.2017.09.008","article-title":"Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome","volume":"31","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.thromres.2013.07.023","article-title":"From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: Pathogenic mechanisms of the antiphospholipid syndrome","volume":"132","author":"Du","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0961203312438631","article-title":"Pathophysiology of thrombotic APS: Where do we stand?","volume":"21","author":"Urbanus","year":"2012","journal-title":"Lupus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of \u03b22 glycoprotein I under various pathophysiologic conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: Understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-\u03b22-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","article-title":"\u03b22-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"Arad","year":"2011","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-014-0485-9","article-title":"The Journey of Antiphospholipid Antibodies from Cellular Activation to Antiphospholipid Syndrome","volume":"17","author":"Willis","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to \u03b22- glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"Guidali","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: A potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J. Autoimmun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.molimm.2012.08.012","article-title":"Anti-beta(2)GPI\/beta(2)GPI induced TF and TNF-alpha expression in monocytes involving both TLR4\/MyD88 and TLR4\/TRIF signaling pathways","volume":"53","author":"Xie","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2007.02310.x","article-title":"Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: Glycoprotein Ibalpha and apolipoprotein E receptor 2\u2019","volume":"5","author":"Pennings","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2141.2001.03101.x","article-title":"Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis","volume":"115","author":"Joseph","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1055\/s-0037-1614881","article-title":"Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome","volume":"82","author":"Velasco","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","article-title":"Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1\/ERK pathway","volume":"54","author":"Buendia","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.13248","article-title":"Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: Induction role of anti-\u03b22-GPI antibodies","volume":"196","author":"Capozzi","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Sem. Immunopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/art.39938","article-title":"In vivo role of neu- trophil extracellular traps in antiphospholipid antibody-mediated venous thrombosis","volume":"69","author":"Meng","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuropharm.2018.06.001","article-title":"Anti-\u03b22GPI\/\u03b22GPI induces neutrophil extracellular traps formation to promote thrombogenesis via the TLR4\/MyD88\/MAPKs axis activation","volume":"138","author":"Zha","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_47","first-page":"66","article-title":"Degradation of neutrophil extra-cellular traps is decreased in patients with antiphospholipid syndrome","volume":"32","author":"Leffler","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.41460","article-title":"Anti-neutrophil extracellular trap anti- bodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1160\/TH11-08-0554","article-title":"Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome","volume":"107","author":"Breen","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for anti-phospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2015-09-672139","article-title":"Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery","volume":"127","author":"Meroni","year":"2016","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40136","article-title":"Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-0897.2011.01007.x","article-title":"Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin","volume":"66","author":"Carroll","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/art.39453","article-title":"ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice","volume":"68","author":"Ulrich","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0897.2009.00805.x","article-title":"Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity","volume":"63","author":"Mulla","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3899\/jrheum.170044","article-title":"Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of \u201cNon-criteria\u201d Antiphospholipid Antibodies","volume":"44","author":"Zohoury","year":"2017","journal-title":"J. Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/keab414","article-title":"\u201cNon-criteria antiphospholipid antibodies\u201d: Bridging the gap between seropositive and seronegative Antiphospholipid Syndrome","volume":"61","author":"Truglia","year":"2022","journal-title":"Rheumatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.148.5.997","article-title":"Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells","volume":"148","author":"Pralle","year":"2000","journal-title":"J. Cell. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1194\/jlr.TR119000383","article-title":"The ins and outs of lipid rafts: Functions in intracellular cholesterol homeostasis, microparticles, and cell membranes","volume":"61","author":"Ouweneel","year":"2020","journal-title":"J. Lipid. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1189\/jlb.1007698","article-title":"Dual acylation and lipid raft association of Src-family protein tyrosine kinases are required for SDF-1\/CXCL12-mediated chemotaxis in the Jurkat human T cell lymphoma cell line","volume":"84","author":"Zaman","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/BJ20061061","article-title":"p56lck, LFA-1 and PI3K but not SHP-2 interact with GM1- or GM3-enriched microdomains in a CD4-p56lck association-dependent manner","volume":"402","author":"Barbat","year":"2007","journal-title":"Biochem. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0006-291X(02)02311-2","article-title":"The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis","volume":"297","author":"Wang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4161\/auto.27959","article-title":"Evidence for the involvement of GD3 ganglioside in autophagosome formation and maturation","volume":"10","author":"Matarrese","year":"2014","journal-title":"Autophagy"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2020.02.004","article-title":"On the role of sphingolipids in cell survival and death","volume":"351","author":"Iessi","year":"2020","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1074\/jbc.273.10.5419","article-title":"Caveolins, a family of scaffolding proteins for organizing \"preassembled signaling complexes\" at the plasma membrane","volume":"273","author":"Okamoto","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.140218797","article-title":"Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface","volume":"97","author":"Heino","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1091\/mbc.e08-05-0517","article-title":"Lipid microdomains in cell nucleus","volume":"19","author":"Cascianelli","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BJ20071704","article-title":"Endosomal compartment contributes to the propagation of CD95\/Fas-mediated signals in type II cells","volume":"413","author":"Matarrese","year":"2008","journal-title":"Biochem. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"26569","DOI":"10.1074\/jbc.M113.489310","article-title":"Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic \u03b2-cells","volume":"288","author":"Boslem","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.cdd.4401672","article-title":"Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells","volume":"12","author":"Garofalo","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-017-0025-4","article-title":"Mitochondria-associated ER membranes (MAMs) and lysosomal storage diseases","volume":"9","author":"Annunziata","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/15548627.2016.1160971","article-title":"Evidence for the involvement of lipid rafts localized at the ER-mitochondria associated membranes in autophagosome formation","volume":"12","author":"Garofalo","year":"2016","journal-title":"Autophagy"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1080\/15548627.2020.1834207","article-title":"Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs","volume":"17","author":"Manganelli","year":"2021","journal-title":"Autophagy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/embo-reports\/kvf022","article-title":"An essential role for membrane rafts in the initiation of Fas\/CD95-triggered cell death in mouse thymocytes","volume":"3","author":"Hueber","year":"2002","journal-title":"EMBO Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20041685","article-title":"Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis","volume":"202","author":"Miyaji","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/smim.2000.0204","article-title":"The role of lipid rafts in T cell antigen receptor (TCR) signalling","volume":"12","author":"Janes","year":"2000","journal-title":"Semin. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"615996","DOI":"10.3389\/fcell.2020.615996","article-title":"Direct Regulation of the T Cell Antigen Receptor\u2019s Activity by Cholesterol","volume":"8","author":"Drechsler","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200420345","article-title":"Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus","volume":"113","author":"Jury","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.4049\/jimmunol.181.6.4019","article-title":"Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation","volume":"181","author":"Deng","year":"2008","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.glycob.a018822","article-title":"New insights in glycosphingolipid function: \u201cglycosignaling domain\u201d, a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling","volume":"8","author":"Hakomori","year":"1998","journal-title":"Glycobiology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2004.02.015","article-title":"Endothelial cell activation by antiphospholipid antibodies","volume":"112","author":"Meroni","year":"2004","journal-title":"Clin. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Misasi, R., Longo, A., Recalchi, S., Caissutti, D., Riitano, G., Manganelli, V., Garofalo, T., Sorice, M., and Capozzi, A. (2020). Molecular Mechanisms of \u201cAntiphospholipid Antibodies\u201d and Their Paradoxical Role in the Pathogenesis of \u201cSeronegative APS\u201d. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218411"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1597290","article-title":"Mechanisms of Cellular Activation in the Antiphospholipid Syndrome","volume":"44","author":"Lackner","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1242\/jcs.01270","article-title":"Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane","volume":"117","author":"Triantafilou","year":"2004","journal-title":"J. Cell. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood-2005-03-1201","article-title":"Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response","volume":"106","author":"Buttari","year":"2005","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"33831","DOI":"10.1074\/jbc.M212655200","article-title":"Dimers of \u03b22-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2","volume":"278","author":"Lutters","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12026-016-8840-8","article-title":"Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipidsyndrome","volume":"65","author":"Weiss","year":"2017","journal-title":"Immunol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","article-title":"High affinity binding of \u03b22-glycoprotein I to human endothelial cells is mediated by annexin II","volume":"275","author":"Ma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bpj.2014.08.027","article-title":"Cooperative binding of annexin A2 to cholesterol- and phosphatidylinositol-4,5-bisphosphate-containing bilayers","volume":"107","author":"Pejic","year":"2014","journal-title":"Biophys. J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"30911","DOI":"10.1074\/jbc.M111.271155","article-title":"Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2","volume":"286","author":"Valapala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Matos, A.L.L., Kudruk, S., Moratz, J., Heflik, M., Grill, D., Ravoo, B.J., and Gerke, V. (2020). Membrane Binding Promotes Annexin A2 Oligomerization. Cells, 9.","DOI":"10.3390\/cells9051169"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.2003.02180.x","article-title":"Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression","volume":"132","author":"Conti","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaut.2004.01.002","article-title":"A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo","volume":"22","author":"Pierangeli","year":"2004","journal-title":"J. Autoimmun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0952-7915(01)00304-1","article-title":"Toll-like receptors: Key mediators of microbe detection","volume":"14","author":"Underhill","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","article-title":"Autoantibodies specific to a peptide of \u03b22-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes","volume":"120","author":"Colasanti","year":"2010","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"eabc0956","DOI":"10.1126\/science.abc0956","article-title":"Lipid presentation by the protein C receptor links coagulation with autoimmunity","volume":"371","author":"Hollerbach","year":"2021","journal-title":"Science"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Riitano, G., Capozzi, A., Recalchi, S., Caissutti, D., Longo, A., Mattei, V., Conti, F., Misasi, R., Garofalo, T., and Sorice, M. (2022). Anti-\u03b22-GPI Antibodies Induce Endothelial Cell Expression of Tissue Factor by LRP6 Signal Transduction Pathway Involving Lipid Rafts. Cells, 11.","DOI":"10.3390\/cells11081288"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2019001530","article-title":"Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis","volume":"134","author":"Hollerbach","year":"2019","journal-title":"Blood"},{"key":"ref_104","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"38650","DOI":"10.18632\/oncotarget.16246","article-title":"Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated \u03b2-catenin stabilization","volume":"8","author":"Nag","year":"2017","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0961203309360542","article-title":"The role of LRP8 (ApoER2\u2019) in the pathophysiology of the antiphospholipid syndrome","volume":"19","author":"Derksen","year":"2010","journal-title":"Lupus"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-018-0023-x","article-title":"Oxidized phospholipids are ligands for LRP6","volume":"6","author":"Wang","year":"2018","journal-title":"Bone Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12079-020-00551-w","article-title":"LRP6 mediated signal transduction pathway triggered by tissue plasminogen activator acts through lipid rafts in neuroblastoma cells","volume":"14","author":"Riitano","year":"2020","journal-title":"J. Cell. Commun. Signal."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/35083081","article-title":"Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6\/Arrow","volume":"3","author":"Bafico","year":"2001","journal-title":"Nat. Cell. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35077108","article-title":"LDL-receptor-related protein 6 is a receptor for Dickkopf proteins","volume":"411","author":"Mao","year":"2001","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Tamai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cellsig.2013.11.021","article-title":"\u03b2-Catenin-dependent pathway activation by both promiscuous \u201ccanonical\u201d WNT3a-, and specific \u201cnoncanonical\u201d WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency","volume":"26","author":"Ring","year":"2014","journal-title":"Cell Signal."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"706731","DOI":"10.3389\/fcell.2021.706731","article-title":"Receptor\/Raft Ratio Is a Determinant for LRP6 Phosphorylation and WNT\/\u03b2-Catenin Signaling","volume":"9","author":"Haack","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_114","first-page":"762","article-title":"Antiphospholipid arterial vasculopathy","volume":"16","author":"Cardiel","year":"1989","journal-title":"J. Rheumatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kem040","article-title":"Vasculopathy and arterial stenotic lesions in the antiphospholipid syndrome","volume":"46","author":"Christodoulou","year":"2007","journal-title":"Rheumatology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.CIR.99.16.2164","article-title":"Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle","volume":"99","author":"Gallo","year":"1999","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.1089353","article-title":"T cell activation by lipopeptide antigens","volume":"303","author":"Moody","year":"2004","journal-title":"Science"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1126\/science.1103440","article-title":"Lysosomal glycosphingolipid recognition by NKT cells","volume":"306","author":"Zhou","year":"2004","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature03408","article-title":"Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections","volume":"434","author":"Mattner","year":"2005","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11926-013-0331-5","article-title":"Use of new oral anticoagulants in antiphospholipid syndrome","volume":"15","author":"Arachchillage","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11926-013-0360-0","article-title":"2013 update: Hopkins lupus cohort","volume":"15","author":"Fangtham","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2004-01-0145","article-title":"Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep","volume":"104","author":"Zhou","year":"2004","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1054-3589(10)59009-4","article-title":"Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention","volume":"59","author":"Holy","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1194\/jlr.TR120000658","article-title":"Lipid rafts as a therapeutic target","volume":"61","author":"Sviridov","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1074\/jbc.C300553200","article-title":"Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides","volume":"279","author":"Arakawa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.111.300581","article-title":"Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1","volume":"112","author":"Umemoto","year":"2013","journal-title":"Circ. Res."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Cheng, A.M., Handa, P., Tateya, S., Schwartz, J., Tang, C., Mitra, P., Oram, J.F., Chait, A., and Kim, F. (2012). Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing toll-like receptor-4 recruitment into lipid rafts. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033917"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI69571","article-title":"Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients","volume":"124","author":"McDonald","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: A non-randomised, open-label, phase 1\u20132 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"36628","DOI":"10.1021\/acsami.8b08243","article-title":"Tumor targeting and lipid rafts disrupting hyaluronic acid-cyclodextrin- based nanoassembled structure for cancer therapy","volume":"10","author":"Lee","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_134","first-page":"e04628","article-title":"Re-evaluation of b-cyclodextrin (E 459) as a food additive","volume":"14","author":"Mortensen","year":"2016","journal-title":"EFSA J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/art.11449","article-title":"Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model","volume":"48","author":"Ferrara","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1161\/STROKEAHA.113.001576","article-title":"Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment","volume":"44","author":"Merwick","year":"2013","journal-title":"Stroke"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glyn","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1538-7836.2004.00896.x","article-title":"Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells","volume":"2","author":"Ferrara","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jri.2009.03.003","article-title":"Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice","volume":"82","author":"Girardi","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/ard.2010.135525","article-title":"Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome","volume":"70","author":"Aguirre","year":"2011","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/891\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:13:55Z","timestamp":1760120035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":141,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jcm12030891"],"URL":"https:\/\/doi.org\/10.3390\/jcm12030891","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}